Kiely John, a director at Amneal Pharmaceuticals ($AMRX), sold shares on the open market twice in the past year for a total of $675 thousand. His most recent sale occurred on August 27, 2025. These transactions rank 5,827th among nearly 12,000 insiders, well below the average sale value of 8.6 million across 6 transactions per person. John made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 27, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | S | Class A Common Stock | 32000 | $9.23 | 225,433.0000 | 308,978,000 | 12.43% | 0.01% |
| May 12, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | S | Class A Common Stock | 50000 | $7.59 | 257,433.0000 | 308,978,000 | 16.26% | 0.02% |
| May 6, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | A | Restricted Stock Units | 34819 | $0.00 | 34,819.0000 | 308,978,000 | 9999.99% | 0.01% |
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | M | Class A Common Stock | 40258 | $0.00 | 307,433.0000 | 308,978,000 | 15.07% | 0.01% |
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | M | Restricted Stock Units | 40258 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.01% |
| Nov. 22, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | S | Class A Common Stock | 17058 | $8.38 | 267,175.0000 | 309,647,000 | 6.00% | 0.01% |
| Nov. 22, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | M | Stock Option | 28506 | $0.00 | 0.0000 | 309,647,000 | 100.00% | 0.01% |
| Nov. 22, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | M | Class A Common Stock | 28506 | $4.76 | 284,233.0000 | 309,647,000 | 11.15% | 0.01% |
| May 10, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | M | Class A Common Stock | 76453 | $0.00 | 255,727.0000 | 176,136,000 | 42.65% | 0.04% |
| May 10, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | M | Restricted Stock Units | 76453 | $0.00 | 0.0000 | 176,136,000 | 100.00% | 0.04% |
| May 2, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | A | Restricted Stock Units | 40258 | $0.00 | 40,258.0000 | 176,136,000 | 9999.99% | 0.02% |
| May 10, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | M | Class A Common Stock | 80128 | $0.00 | 179,274.0000 | 150,944,000 | 80.82% | 0.05% |
| May 9, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | A | Restricted Stock Units | 76453 | $0.00 | 76,453.0000 | 150,944,000 | 9999.99% | 0.05% |
| May 10, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Kiely John | Director | M | Restricted Stock Units | 80128 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 0.05% |